Epidermal human keratinocytes are exposed to a wide range of environmental genotoxic insults, including the UV component of solar radiation. Epidermal homeostasis in response to cellular or tissue damage is maintained by a population of keratinocyte stem cells (KSC) that reside in the basal layer of the epithelium. Using cell sorting based on cell-surface markers, we have identified a novel a6 integrin high+ /CD44
Introduction
The human epidermis is a stratified epithelium that maintains its integrity through a process of constant regeneration, driven by a population of keratinocyte stem cells (KSCs) in the basal layer [1] . The search to identify human KSCs has focused on the principle of adhesion to the basement membrane. In vitro it has been shown that the keratinocytes that rapidly adhere to cell culture plates form tightly packed colonies, termed holoclones, which have the greatest long-term growth potential and so are likely to contain stem cells [2, 3] . b1 integrin and a6 integrin expression is found on the basal surface of basal layer keratinocytes in vivo and identifies cells with a high growth potential in vitro [4, 5] . Malignancies display the common characteristic of excessive proliferation, suggesting that tumour growth is driven by a subset of malignant stem cells [6, 7] . The cell adhesion receptor CD44 has been shown to be expressed on the surface of tumour initiating cells in solid tumours of the breast [8] , pancreas [9] , prostate [10] and squamous cell carcinomas of the head and neck (SCCHN) [11] . In vitro, CD44-positive tumour cells display self-renewal properties indicative of stem cell behaviour [12] . Whilst the expression of CD44 in the epidermis has been confirmed [13] , this surface protein is currently not thought to play a role in driving keratinocyte cell growth.
The epidermis is frequently exposed to sunlight, with the ultra-violet B (UVB) fraction of the radiation able to penetrate the surface of the epidermis, directly damaging the DNA of the keratinocytes via formation of cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts [14] . The response of the keratinocytes to DNA damage is to undergo cell cycle arrest. If the damage is repairable via the nucleotide excision repair complex (NER) [15] the cell returns to the normal cell cycle. If DNA damage repair is not possible, the cell undergoes programmed cell death [16] . Following the shedding of apoptotic 'sunburn' cells from the surface, the epidermis repopulates to maintain the stratified epidermal barrier, indicating a sub-population of cells survives apoptotic induction.
In cancer cell lines CD44-positive cells have been shown to display a resistance to apoptosis following treatment with chemotherapy agents [17] . The aim of this study is to identify if there is a population of basal human keratinocytes that are positive for expression of CD44 and display an altered apoptotic response compared to the rest of the cell population. Here we report that a fraction of keratinocytes with the a6 integrin high+ / CD44
+ phenotype display a high growth potential, are able to resist cell death following UVB irradiation through high expression of TAp63 and activation of the PI3-kinase pathway, yet are sensitive to cell death induced by the cisplatin-activated cabl pathway.
Materials and Methods

Cell Culture
Primary human keratinocytes were isolated from redundant facelift skin and passage 2-3 cells were used in all experiments unless otherwise stated. Keratinocytes were grown on mitomycintreated 3T3 feeder layers in growth factor-containing medium (DMEM-F12 modified medium, PAA, Yeovil, UK) supplemented with 10% foetal bovine serum (FBS) (Biowest, East Sussex, UK), 1% (vol/vol) glutamine, 5 mg/ml insulin, 0.4 mg/ml hydrocortisone, 5 mg/ml transferrin, 10 210 M cholera toxin, 0.013 mg/ml lyothyronine (Sigma, Poole, UK) and 10 ng/ml EGF (Serotec, Oxford, UK) at 37uC in 10% CO 2 .
Immunofluorescence
Frozen skin sections and primary human keratinocytes were fixed with 4% paraformaldehyde for 10 min at room temperature, washed with PBS, permeablised by incubating with 0.2% (v/v) Triton X in PBS for 5 min at RT if required and blocked with 5% donkey serum (Sigma, Poole, UK) at room temperature for 1 hour. Primary antibodies against human a-6 integrin (CD49f, BD Bioscience, Oxford, UK), human CD44 (AbD Serotec, Oxford, UK) or human total p63 (Santa Cruz Biotechnology, Heidelberg, Germany) were incubated at 4uC overnight with a further 3 washes completed before incubation with the relevant donkey secondary antibodies (Molecular Probes, Paisley, UK) at room temperature for 1 hour. Cells were then mounted with coverslips using Vectashield-DAPI mounting medium (Vectorlabs, Petersfield, UK) and analysed using a Nikon Eclipse TC2000S microscope (Nikon, Kingston, UK).
Flow Cytometry
Cells were grown at clonal density until they reached 60% confluence (5 days), washed with PBS and removed from the culture dish using trypsin-EDTA (PAA, Yeovil, UK). Following neutralisation and washing with PBS the cells were resuspended at 1610 6 /ml in PBS/1% FBS with 5610 5 cells used per incubation and analysis. Incubation was at 4uC for 30 min using CD44-FITC and CD49f-PE-Cy5 conjugated antibodies (BD Bioscience, Oxford, UK). Simultaneously cells were incubated with the corresponding IgG isotype controls (BD Bioscience, Oxford, UK). Cells were then washed in PBS/1% FBS and either recorded as live cells on a BD LSRII FACS machine or fixed cells following treatment with 1% paraformaldehyde. FACSDiva software was used to analyse all samples, with isotype and single-colour negative controls used to establish compensation settings, and a minimum of 30,000 events recorded per sample. For sorting of the cells a BD FACSAria machine was used. Other live cell-surface flow cytometry analysis used the BD antibodies b1 integrin (CD29-APC), transferrin receptor (CD71) with biotynilated-PE secondary, and appropriate IgG isotype controls (BD Bioscience, Oxford, UK). The FITC, PE and PE-Cy5 antibodies were excited using an argon laser (488 nm) and collected using a 530/30 nm filter (FITC), 575/26 nm filter (PE), and 675/20 nm filter (PE-Cy5). The APC antibody was excited using the 633 nm red diode and collected using a 660/20 nm filter.
Cell Proliferation Assay
To determine the proliferative capacity in vitro of subpopulations of keratinocytes, cells were fractionated on the basis of their cell surface phenotype and grown in a long-term culture experiment. Following sorting, the sub-populations were seeded out at an initial density of 5610 3 cells per well of a 24-well plate onto a 3T3 feeder layer. In addition the relative 'remainder' fractions and total un-fractionated cell population (UF) were plated. All fractions per experiment were plated in triplicate, carried in parallel and passaged at the same time. At first passage all cells from each fraction were pooled and plated equally into three wells of a 6-well plate. At subsequent passages, cells from each well were counted and re-plated at 5610 4 cells per well of a 6-well plate, irrespective of cell yield. Serial passaging continued until each fraction had been grown to exhaustion. The cumulative total cell output for the initial fraction (5610 3 cells) was calculated assuming that all cells had been replated at each passage. Total cell output per original fractionated cell in each population was then calculated.
Apoptosis Induction
Cells plated in dishes were grown to 50% confluence (4 days) and washed in PBS. A thin layer of PBS was added prior to UVB irradiation at increasing doses from 1 to 40 mJ/cm 2 . UVB irradiation was from a UVP Multiple Ray Lamp (Ultra-violet Products, Cambridge, UK) (MRL-58 model) fitted with F8T5 bulbs producing a sharp emission at 312 nm corresponding to mid-range UVB, calibrated before each experiment with a UVX Radiometer (UVP, Cambridge, UK). The PBS was then replaced with medium and cells grown for a further 6 to 48 hours dependent upon apoptosis assay. Chemical induction involved addition of chemotherapeutic drugs to the cell culture medium at increasing final doses; Etoposide 10-100 mg/ml, Cisplatin 25-200 mg/ml, Camptothecin 0.5-4 mM and Bleomycin 25-200 mg/ ml (Sigma, Poole, UK) for 24 to 72 hours. The PI-3 kinase inhibitors Wortmannin (1 mM) and LY294002 (50 mM) and the tyrosine kinase inhibitor imatinib (1 mM) were added 2 hr prior to apoptosis induction. Doses of all drugs were chosen following preliminary dose-response assays, IC50 values of the drugs and previous relevant studies.
Apoptosis Detection
Live cells were analysed for Annexin-V binding (Annexin V-FITC antibody, BD Bioscience, Oxford, UK) using the cell surface staining method described above followed by an incubation with the antibody in Annexin-V Binding Buffer (BD Bioscience, Oxford, UK) for 15 min at room temperature, a wash with PBS and the addition of 200 ng/ml DAPI directly prior to flow cytometry analysis to distinguish non-viable cells.
For Caspase-3 detection cells grown in 6-well plates were fixed with 4% paraformaldehyde, washed with PBS and permeablised with 0.2% Triton-X 100 in PBS for 5 min at room temperature. Cells were blocked using 5% goat serum/0.1% Tween 20 in PBS for 2 hours and washed 61 in PBS. Rabbit anti-human AntiActive Caspase-3 (Promega, Southampton, UK) was incubated at 1:250 in 5% goat serum/1% Tween 20/PBS overnight at 4uC. Cells were washed in PBS (10 min62), in 1% Tween 20/PBS (10 min62) and in PBS (10 min62). The 2u antibody Alexa Fluor 488 goat anti-rabbit IgG (H+L) (Invitrogen) was incubated 1:500 in PBS for 2 hours at room temperature. Cells were washed in PBS (5 min62), 1% Tween 20/PBS (5 min61) and PBS (5 min61). Cells were mounted using DAPI mounting medium and coverslips with fluorescence viewed using the Nikon Eclipse TE 2000-S microscope.
Cells analysed for TdT-mediated dUTP nick end-labelling (TUNEL) were removed from the dish, incubated with cell surface antibodies and fixed overnight as described earlier. Cells were then washed in PBS (x2), incubated in TUNEL (Promega) at 37uC for 1 hour, washed in PBS x1 and Triton-X 100 (5 min x1) before addition of 1 mg/ml DAPI in PBS 30 min before flow cytometry analysis.
QRT-PCR
Total RNA was extracted from keratinocytes using the RNeasy Micro Kit (Qiagen, West Sussex, UK) according to manufacturer's instructions. cDNA was generated using the SuperScript III FirstStrand Synthesis SuperMix Kit (Invitrogen, Paisley, UK). Positive controls were transcribed from total human RNA (Stratagene QPCR Human Reference Total RNA, Agilent Technologies UK Limited, Stockport, UK) and negative controls with the omission of sample RNA (no template control, NTC) or omission of RT Enzyme Mix (no reverse transcriptase control, -RT). qRT/PCR was performed with Syber Green PCR master mix (Applied Biosystems, Warrington, UK) and results analysed using 7500 System Software (Applied Biosystems). The reaction was run at 95uC for 10 min followed by 45 cycles at 95uC for 15 s, 60uC for 30 s and 72uC for 40 sec and then one cycle at 95uC for 1 min. Forward (39 to 59) and reverse (59 to 39) primers were designed for DNp63 (Forward GGAAAACAATGCCCAGACTC, Reverse GTGGAATACGTCCAGGTGGC) and TAp63 (Forward AA-GATGGTGCGACAAACAAG, Reverse AGAGAGCATC-GAAGGTGGAG). Quantification was obtained by normalising the target genes against the GAPDH (Forward CACCCAGAA-GACTGTGGATGG, Reverse GTCTACATGGCAACTGT-GAGG) or 28s-r-RNA (Forward GCCGGGGGCCTCCCACT-TAT, Reverse TGGCGGAATCAGCGGGGAAA) housekeeping genes.
Results
High Expression of CD44 and a6 Integrin Identifies a Subset of Human Keratinocytes with a High Proliferative Capacity in vitro
In line with previous studies, expression of CD44 was observed in both the basal and suprabasal layers of the human epidermis in vivo [13] while a6 integrin was restricted to the basal layer only [4] ( Figure 1A ). Quantification by flow cytometry of the in vitro expression of CD44 and a6 integrin was detected at 10% and 30% of the total human keratinocyte population respectively ( Figure 1B ). Using two-colour flow cytometry a manual gate was set to analyse basal, a6 integrin-expressing cells (a6 integrin high+ ) that also expressed CD44 (CD44 + ). This fraction (a6 integrin high+ /CD44 + ) averaged ,5% of the total keratinocyte population ( Figure 1C ) and when plated in culture these cells grew to produce large colonies with a tightly-packed holoclone-like morphology ( Figure 1D ). In contrast, the a6 integrin 2/ CD44 2 fraction produced only very small, sparse paraclone-like colonies in culture with many keratinocytes remaining as large, single cells indicative of a more differentiated morphology. Whilst both the a6 integrin +/ CD44 2 and a6 integrin 2/ CD44 + fractions appeared to mainly form meroclone-like colonies.
To establish if there were measurable differences in the longterm growth of the a6 integrin high+ /CD44 + cells compared to the rest of the keratinocyte population, the total cell output was quantified ( Figure 1E ). When passaged until exhaustion, each a6 integrin high+ /CD44 + cell produced a significantly greater cell output than the remainder population and the UF control (p,0.05). In parallel, the recognised keratinocyte stem cell phenotypes b1 integrin + [3] and a6 integrin bri /CD71 ldim [5] , together with their relative remaining populations (here deemed b1 integrin 2 and a6 integrin dim /CD71 bri ), were run as controls. As expected, both the b1 integrin high and the a6 integrin bri / CD71 dim fractions produced a larger cell output than their corresponding remainder fractions and the UF cells, although these differences were not significant (p.0.05). The level of b1 integrin + and CD71 dim expression in the a6 integrin high+ /CD44 + fraction was quantified at 57% and 42% respectively ( Figure 1F ). (Figure 2A ). Keratinocytes exposed to higher doses (.10 mJ/cm 2 ) displayed apoptotic damage including membrane blebbing, punctated nuclei and cells lifting from the dish. The change in the early apoptotic marker Annexin-V was compared between the a6 integrin high+ /CD44 + cells and remainder keratinocytes using flow cytometry quantification. At 6 hours following UVB irradiation, no significant apoptotic changes were evident in either fraction (p.0.05, Figure 2B ). [18] and camptothecin binds to Topoisomerase I leading to replication-induced double strand breaks [19] . When increasing doses of the genotoxic agents (etoposide; 10 to 100 mg/ml and camptothecin; 0.5 mM to 4 mM) were added to cultured keratinocytes, the resultant Annexin-V quantification at 24 hr using flow cytometry produced similar patterns to that obtained post-UVB irradiation. A dose-dependent rise in apoptosis was observed in the remainder population, yet the a6 integrin high+ /CD44 + fraction showed significant resistance to apoptosis (p,0.05, Figure 3A and p,0.01, Figure 3B ). The antibiotic drug bleomycin cleaves DNA to produce both single and double strand breaks [20] . Addition of bleomycin (35 to 200 mg/ml) produced a similar dose-response pattern in the remainder fraction of increased Annexin-V binding 24 hr post-treatment ( Figure 3C ). In the a6 integrin high+ /CD44
+ fraction an increase in apoptosis was observed above control, but this did not rise in conjunction with increased dose and was still significantly lower than the remainder population (p,0.05). Treatment with the platinum DNA cross-linking agent cisplatin produced an altered apoptotic response in the keratinocytes. As the concentration of cisplatin (25 to 200 mg/ml) administered to the keratinocytes was increased, the level of Annexin-V binding rose in both the remainder and a6 integrin high+ /CD44
+ populations ( Figure 3D ).
Cell Death is Apoptotic in Origin
Immunofluorescence staining to visualise the later-stage apoptotic marker of active Caspase-3 revealed a greater number of active Caspase-3 positive cells were present at 48 hr in keratinocytes treated with either UVB or cisplatin compared to untreated control cells ( Figure 4A ).
Flow cytometry was used to analyse the number of TUNEL tation from the control was significantly higher in the remainder fraction than the a6 integrin high+ /CD44 + fraction after UVB irradiation (p,0.05, Figure 4B ). Whereas the number of cells in the last stage of programmed cell death was very similar in both fractions following cisplatin treatment (p.0.05).
Inhibition of the PI 3-kinase Survival Pathway Sensitises the a6 Integrin high+ /CD44 + Keratinocytes to UVB-induced Apoptosis
To identify if the PI3-kinase cell survival pathway is protecting the a6 integrin high+ /CD44 + fraction, the cells were probed for expression of the activated downstream effector pAKT. An
Simultaneously, keratinocytes were fractionated on the basis of b1 integrin expression (b1 integrin high ) or a6 integrin and transferrin receptor (a6 integrin bri /CD71 dim ) and the corresponding remainder populations (b1 integrin low and a6 integrin dim /CD71 bri ). The total cell output from the cells of each fraction was calculated after serial culture in vitro until exhaustion (average , 42 days, n = 3). Data represents mean cell yield 6 SEM of three replicates. Statistical significance was determined using the paired Student's t-test, *P,0.05. (F) Positive expression of b1 integrin (CD29) and low expression of the transferrin receptor (CD71 dim ) were analysed in the a6 integrin high+ /CD44
+ fraction using flow cytometry. Antibody fluorescence is depicted as shaded histograms and the relevant isotype controls as unshaded histograms (n = 3). doi:10.1371/journal.pone.0046968.g001 + and remainder populations and plotted as a change in percentage from the control level (0 mJ/cm 2 which averaged ,8% apoptosis) to negate the necrotic cells present before treatment. Results show apoptosis levels 6, 16 and 24 hours after UVB irradiation of colonies at 50% confluency. Keratinocytes were also UVB irradiated as single cells 2 hours after plating, and apoptosis levels are shown after 24 hours. Data represents the mean 6SEM where n = 3. Statistical significance was determined using the paired Student's t-test **P,0.01, *P,0.05. doi:10.1371/journal.pone.0046968.g002 Figure 3 . Drug-induced apoptosis. Keratinocytes at 50% confluency treated were with genotoxic agents at increasing doses and analysed for apoptotic cells using flow cytometry. Annexin-V + cells (DAPI + and DAPI 2 ) were totalled in both the a6 integrin high+ /CD44 + and remainder cell populations and plotted as a change in percentage from the control (vehicle only control that averaged ,10% apoptosis). Results show apoptosis levels 24 hours after treatment with Etoposide (A), Camptothecin (B) Bleomycin (C) and Cisplatin (D). Data represents the mean 6SEM where n = 3. Statistical significance was determined using the paired Student's t-test **P,0.01, *P,0.05. doi:10.1371/journal.pone.0046968.g003 increase in positive nuclear expression of pAkt Ser473 was observed following UVB irradiation, but no difference between the fractions could be identified using immunofluorescence ( Figure 5A ). No positive nuclear expression of pAkt Ser473 was observed post-UVB when the PI 3-kinase pathway had been inhibited using Wortmannin or LY294002 prior to irradiation ( Figure 5B ). PI3-kinase pathway inhibition using Wortmannin or LY294002 sensitised the a6 integrin high+ /CD44 + keratinocytes to apoptotic cell death. The rise in TUNEL + cells was comparable between the a6 integrin high+ /CD44 + cells and the remainder fraction when quantified by flow cytometry (p.0.05, Figure 5C ).
p63/c-abl Network Activated in Cisplatin-induced Cell Death in a6 Integrin high+ /CD44 + Keratinocytes
The full length TAp63 isoform of the proposed keratinocyte stem cell marker p63 [21] , itself identified as an initiator of apoptosis [22] , was found to be expressed at a significantly higher + cells compared to the remainder population when quantified using QPCR (p,0.05, Figure 6A ). Gene expression of the truncated DNp63 isoform did not differ between the two keratinocyte fractions. Cisplatin treatment appeared to reduce the gene expression levels of the DNp63 isoform, with little difference observed between the a6 integrin high+ /CD44 + and remainder populations (p.0.05, Figure 6B ). mRNA levels of the TAp63 isoform also reduced following cisplatin treatment, with the a6 integrin high+ /CD44 + cells displaying a significant decrease from the control level (p,0.05). Following UVB irradiation, the levels of both p63 isoforms decreased slightly in both populations (p.0.05, Figure 6C ). Addition of the tyrosine kinase inhibitor imatinib prior to cisplatin treatment significantly reduced the amount of cell death seen in the a6 integrin high+ /CD44 + keratinocytes compared to treatment with cisplatin alone (p,0.05, Figure 7A ). Whilst the remainder population did display a decrease in the level of apoptosis, this was not as marked as that seen in the a6 integrin high+ /CD44 + keratinocytes, nor significant (p.0.05). Gene expression of the DNp63 and TAp63 isoforms did not alter from the control (vehicle-only) level in the remainder keratinocyte population when treated with imatinib prior to cisplatin ( Figure 7B) . The significantly higher level of TAp63 mRNA quantified in the a6 integrin high+ /CD44 + fraction did not decrease in response to cisplatin with imatinib. This is in contrast to the decrease in the gene expression of this isoform reported in the cisplatin-only treatment.
Analysis of the location of the total p63 protein in the a6 integrin high+ /CD44 + keratinocytes revealed positive nuclear expression evident in the control cells ( Figure 7C ). The positive nuclear expression was lost when the cultured cells were treated with cisplatin, yet regained with the addition of imatinib prior to cisplatin. This pattern was repeated in the remainder population of keratinocytes.
Discussion
Here we report the identification of a small basal fraction of cultured human primary keratinocytes that express CD44 and display a high growth capacity coupled with an enhanced resistance to apoptosis induced by UVB and specific DNA damaging agents.
Separation of cultured cells expressing high levels of the adhesion molecule a6 integrin enabled selection of the lessdifferentiated basal keratinocyte population. Analysis of the integrin high+ cells for positive CD44 expression revealed a coexpressing population that could be manually gated at ,5% of the total keratinocyte population (a6 integrin high+ /CD44 + cells). The morphology of the colonies formed in culture by this fraction of cells were predominantly holoclone-like in appearance and when passaged until exhaustion, the total cell output was of an equivalent level to that produced by recognised KSC phenotypes b1 integrin high and a6 integrin bri /CD71 dim . When directly analysed for b1 integrin expression or low levels of CD71, the a6 integrin high+ /CD44
+ fraction contained a large number of cells previously identified as KSCs as well as other un-differentiated transient-amplifying cells.
To determine if this population displayed a different apoptotic capability compared to the rest of the cell population, the response of the cells to UVB irradiation was explored. The a6 integrin high+ / CD44
+ fraction displayed a significantly decreased level of apoptosis compared to the rest of the keratinocytes. Interestingly, a6 integrin has also been shown to be required for the growth and + population from the remainder population 6 SEM of three replicates, normalised against GAPDH housekeeping gene. Keratinocytes analysed for gene expression after cisplatin (B) or UVB (C) where data represents the log mean fold change from the control (vehicle-only) 6 SEM of three replicates, normalised against 28S-r-RNA housekeeping gene. Statistical significance was determined using the paired Student's t-test, *P,0.05. doi:10.1371/journal.pone.0046968.g006
survival of breast cancer cells [23] , and an increased expression of CD44 has been observed in cells displaying an apoptotic resistance, in line with a decreased p53 expression [22] or an increased p63 expression [24] . Evaluation of the p63 mRNA levels in our a6 integrin high+ /CD44
+ keratinocytes produced surprising results. QRT-PCR quantification demonstrated a significantly higher mRNA level of the TAp63 isoform, rather than the DNp63 isoform, present in the a6 integrin high+ /CD44 + cells compared to the remainder population (p,0.05). This was unexpected due to the a6 integrin high+ /CD44 + phenotype being selected on the basis that these were the CD44-expressing cells co-expressing the basal layer marker a6 integrin. The truncated form of p63 (DNp63), lacking the NH2-terminal transactivation domain of the full length TAp63 isoform, has repeatedly been identified as the predominant isoform of p63 detected in the basal layer of the human and the murine epidermis [25] and has also been proposed as an inhibitor of apoptosis in the epidermis [26] . This isoform has also been shown to induce integrin expression in murine keratinocytes [27] . TAp63 has been found at only very low levels in the epidermis and in isolated keratinocytes [25] and was identified as an initiator of apoptosis in a wide range of tissues [26] . However, in line with our findings, researchers have begun to question the proposed apoptosis-associated role of TAp63 in the epidermis. Analysis of p63 expression in mice during gestation revealed that TAp63 is actually the dominant isoform present from E7.5 to E15 [28] . Interestingly, overexpression of TAp63, rather than DNp63, leads to a significant reduction in the level of apoptosis after UVB irradiation in murine keratinocytes [29] . Analysis of the TAp63 Figure 7 . Effect of imatinib on keratinocyte apoptosis and p63 expression. (A) Primary keratinocytes treated with 50 mg/ml cisplatin, or 1 mM imatinib, or 1 mM imatinib for 2 hr and then 50 mg/ml cisplatin were analysed for TUNEL expression 24 hour post-treatment. TUNEL-positive cells were totalled in the a6 integrin high+ /CD44
+ and remainder populations and plotted as a percentage change from control level. Data represents the mean 6 SEM where n = 3. Statistical significance was determined using the paired Student's t-test, *P,0.05.) (B) QRT-PCR quantification of p63 gene expression in a6 integrin high+ /CD44
+ and remainder keratinocyte populations 16 hr after treatment with 1 mM imatinib and 50 mg/ml cisplatin. Data represents the log mean fold change from the control (vehicle-only) for each population 6 SEM of three replicates. All results were normalised against the 28s-r-RNA housekeeping gene. Statistical significance was determined using the paired Student's t-test (P.0.05 in all cases). (C) FACSseparated a6 integrin high+ /CD44
+ cultured keratinocytes were probed for p63 expression (green) using immunofluorescence 16 hr following treatment with 50 mg/ml cisplatin and/or 1 mM imatinib. The control cells were treated with vehicle-only and the negative control was prepared with the secondary antibody only. Nuclei were detected with DAPI (blue) and images are representative of n = 2. The scale bar is equal to 100 mm. doi:10.1371/journal.pone.0046968.g007 mRNA after UVB irradiation in our a6 integrin high+ /CD44 + human keratinocytes showed a slight decrease in the gene expression level, but was not significant. The lack of any rise could demonstrate that TAp63 is not taking on a pro-apoptotic role in the keratinocytes and the lack of significant decrease could infer that it is the high basal level of TAp63 that is offering resistance to UVB-induced apoptosis in this human population. This is in agreement with the finding in the murine keratinocytes that the basal level of TAp63 infers a resistance to UVB-induced apoptosis. Apoptosis is augmented following a loss of the basal TAp63 through siRNA knockdown of the protein [29] . In the murine keratinocytes, inhibition of UVB-induced apoptosis was linked to an increase in phosphorylation of the cell survival protein Akt (pAkt Ser473 ), induced by the increased TAp63 expression. It was confirmed in this study that the PI 3-Kinase pathway plays a role in the human a6 integrin high+ /CD44 + apoptotic resistance, for the survival of the cells was abolished when inhibitors of the PI 3-Kinase pathway were added prior to UVB irradiation. The inhibitors rendered the a6 integrin high+ /CD44 + keratinocytes as sensitive to UVB-induced apoptosis as the rest of the cultured cell population. It was also confirmed that addition of these inhibitors did not lead to the increase in nuclear pAkt Ser473 expression observed following UVB irradiation-alone.
The a6 integrin high+ /CD44 + keratinocytes were also significantly resistant to DNA damage induced by the chemotherapeutic agents etoposide and camptothecin. The striking sensitivity to cisplatin was in contrast to the resistance noted in epithelial cancer stem cell lines [12] . Recent research conducted in mouse oocytes had established the presence of a cisplatin-induced pathway of apoptosis involving the tyrosine kinase c-abl. In particular, the dominance of the role of TAp63 was in activating this c-ablpathway was demonstrated [30] . However, when p63 mRNA levels were examined in the a6 integrin high+ /CD44 + cells following cisplatin treatment, a significant decrease in TAp63 was observed. This implies that the loss of the basal level of TAp63 has reduced the associated resistance of the cells, as opposed to an increase that could infer a TAp63/c-abl apoptotic pathway is present. In accordance, a loss of nuclear p63 protein expression was observed following cisplatin treatment of the cultured cells rather than a stabilisation, or increase, in protein expression via c-abl activation following cisplatin-induced DNA damage [30] . Interestingly, addition of the tyrosine kinase inhibitor imatinib caused the resistance of the a6 integrin high+ /CD44
+ to be increased, so that the cells were significantly resistant to cisplatin-induced apoptosis compared to the rest of the population. This finding indicates the presence of a specific cisplatin-activated tyrosine kinase is able to overcome the basal resistance of the cells seen in response to other genotoxic agents. This basal resistance is again linked back to p63, with the observation that the p63 protein is returned to the control-location of the nucleus when imatinib is added prior to cisplatin treatment.
In conclusion, we have identified a sub-population of cultured human keratinocytes expressing high levels of CD44 and a6 integrin that display a high growth capacity. These a6 integrin high+ /CD44
+ cells display a resistance to undergo programmed cell death in response to UVB irradiation and chemotherapeutic drugs, except in the case of cisplatin treatment where a sensitivity to undergo apoptosis in line with the rest of the cell population is observed. The resistance to UVB-induced apoptosis could be an important property that allows the regenerative capacity of the undifferentiated cells in the human skin to be maintained despite acute UVB-exposure. The mechanism of this resistance appears to be attributed to a high level of baseline TAp63 gene expression linked to the PI 3-Kinase cell survival pathway. The contrasting sensitivity to cisplatin treatment appears to be due to the ability of the drug to cause a loss of this TAp63-conferred protection. This loss is likely to be due to the cisplatin-induced activation of a tyrosine kinase causing a reduction in TAp63 gene expression and nuclear p63 protein levels. Addition of a tyrosine kinase inhibitor reduces the apoptotic sensitivity of the cells to cisplatin, so they are able to demonstrate a resistance to the platinum agent-induced apoptosis. Correspondingly, the high baseline TAp63 mRNA expression does not decrease and the nuclear expression of the p63 protein is not lost.
The notion that a network of TAp63-linked apoptotic protection is present in a population of undifferentiated human keratinocytes may provide important information regarding the behaviour of long-lived cells in the human epidermis. If the resistance to undergo cell death following UVB irradiation is repeated in vivo, the keratinocyte sub-population identified here could provide evidence regarding the PI 3-Kinase regulated cell survival. The possibility that proliferative cells could be retaining UVB-induced mutations and undergoing subsequent transformation would link in with the evidence that epidermal squamous cell carcinomas (SCCs) routinely display a high level of p63 expression. Correspondingly, the finding that these cells are particularly sensitive to cisplatin could provide evidence on how to target and treat the population with chemotherapeutic agents.
